BECOMING A SUPPLIER TO SEQIRUS

Project Overview:

Seqirus, the world’s second largest influenza vaccine provider announced plans to construct a new world-class biotech manufacturing facility in Melbourne, Australia to supply influenza vaccines to Australia and the rest of the world, plus Australian antivenoms and Q-Fever vaccine.

Seqirus is a wholly owned subsidiary of CSL Limited, which will invest more than AUD$800 million in capital expenditure to construct the facility. The building is expected to be operational by mid-2026.

The state-of-the-art facility will use innovative cell-based technology to produce influenza vaccines for use in both influenza pandemics and seasonal vaccination programs – and will be the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere.

The facility will also manufacture Seqirus’ proprietary adjuvant MF59® - a substance added to some vaccines to help improve immune response and to reduce the amount of antigen needed for each vaccine, enabling more doses to be manufactured more rapidly in a pandemic situation.

In addition, the facility will produce unique products important to Australia’s public health needs – including antivenom for Australian snakes, spiders and marine creatures, and the world’s only human vaccine for Q-Fever.

Our Strategic Sourcing Process

At Seqirus, and across the CSL group, we follow a strategic sourcing process to ensure the chosen supplier is aligned with our overall company values and are capable of meeting innovation, cost, quality and time criteria of the project. Our Strategic sourcing process encompasses engagement of cross-functional teams to ensure a fair, transparent and effective process is undertaken.

Key Categories Supported:

Our Procurement team supports a number of different categories to ensure Project Objectives are achieved and to identify supplier capabilities to support operations of the facility when functional. Below is the indicative list of categories that is of interest to the project.

Project phase		Operation phase
Capital goods	Service	Direct Spend	Indirect Spend
Hygienic Vessels	Electrical installation	Raw Materials and Packaging	Building maintenance
Seed & Perfusion Bioreactors	Automation engineering	Buffers, Media and Solutions	Security
Microfluidizer	Civil construction		Waste Disposal Services
Parts Washers	Piping installation		Cleaning Services
(Clean in Place) CIP Skids	Process & Utility Engineering		IT (Hardware, Software and Digital Technology)
Harvest Filter Skid	Logistic service provider		(Maintenance, Repair & Operations) MRO Services and Supply
Temp Control Unit (TCU) Skids	IT service		Professional Services (Labour Hire and Business Consultancy)
(Microfiltration) MF unit
Ultracentrifuge			Warehousing and Logistic service provider
(Water for injection) WFI Stills			Office supplies
Autoclaves			Facilities Management
Platform Lifts			Building Automation
Lab Isolators			Trades (Example: Electrical, Plumbing, Fabrication)
Chromatography columns and Skids
Case packing & palletising
Instruments
Electrical cabinet
Various lab equipment

Registration of interest

If your organisation provides products or services in any of the above listed categories or other relevant categories  and wish to  be considered for any future sourcing events please email your organisation information to Vendorenquiries.banksia@seqirus.com.

Please note invitation to tenders will be made under the sole discretion of Seqirus.